{"atlas_id":"pmmr-mucinous-colon","claim_ceiling":"cross-collection evidence routing for tiered targets only; observed deposited contacts, intervention labels, and target-level measured compound records remain within their source claim ceilings. This matrix does not assert approval status, extracellular site localization of an intervention or compound, mechanism, affinity, efficacy, selectivity, safety, candidate quality, promotion, or patient-specific applicability.","counts":{"compound_coverage_states":{"not-measured":40,"queried-no-selected-records":3,"represented":7},"explicit_proposed_molecular_jobs":52,"matrix_targets":50,"measured_compound_records":57,"records_requiring_discovery_job":30,"records_with_observed_action_labels":12,"records_with_observed_deposited_sites":12,"records_with_observed_intervention_actions":19,"records_with_proposed_modality_lanes":50,"site_coverage_states":{"derived-deposited-site":10,"not-evaluated-in-this-demo-tier":38,"supplemental-prepared-site-available":2},"tier_counts":{"structure-a":10,"structure-b":20,"structure-c":20},"unresolved_proposed_molecular_jobs":30},"policy":{"action_normalization":"split semicolon-delimited source action labels, trim whitespace, case-fold, then count each assigned intervention once per normalized label","determinism":"sorted local joins on hash-bound source JSON; no clock, network, provider, candidate, or promotion input","policy_id":"tiered-target-action-modality-matrix/v0.1","scope":"exactly the canonical Structure-A/B/C targets (10/20/20); separate from opportunities and execution records","state_contract":{"derived":"deterministic join, count, or provisional cell-route derived from source fields","not_measured":"source collection lacks an applicable measured or evaluated record; it is not a negative conclusion","observed":"facts copied from canonical source records","proposed":"planning route only, never a candidate, mechanism, site choice, promotion, approval, efficacy, selectivity, or patient-specific claim"}},"records":[{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"therapeutic-antibody-epitope":1},"partner_class_counts":{"therapeutic-antibody-fab":1},"pdb_ids":["8BW0"],"site_count":1,"site_ids":["SITE-RCSB-8BW0-tusamitamab-fab"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"queried-no-selected-records","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"queried-no-selected-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":100.0,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":92,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":90,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":82,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":23,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"molecular-imaging":1},"action_representatives":[{"action":"molecular-imaging","representative_intervention_ids":["I-CTG-sgm-101-3d31779152"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":13,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody":2,"car-nk-cell-therapy":2,"car-t-cell-therapy":4,"molecular-imaging-agent":4,"radioligand-therapy":1},"registry_intervention_type_counts":{"BIOLOGICAL":6,"DRUG":3,"PROCEDURE":1,"RADIATION":2,"multiple":1},"representative_intervention_ids":["I-CTG-111in-in-dota-anti-cea-antibody-injection-db4657027f","I-CTG-anti-cea-car-t-7a15bcb339","I-CTG-anti-cea-car-t-cells-a8afa7bb5a","I-CTG-cea-targeted-car-t-cells-716275dc4a","I-CTG-copper-cu-64-anti-cea-monoclonal-antibody--1c38eaff9c"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","no-selected-measured-compound-records-in-bounded-source-coverage"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"therapeutic-antibody-epitope","partner_class":"therapeutic-antibody-fab","partner_role":"therapeutic-binder","site_id":"SITE-RCSB-8BW0-tusamitamab-fab"},"basis_ids":["SITE-RCSB-8BW0-tusamitamab-fab","PDB:8BW0"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-8BW0-tusamitamab-fab","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"},{"basis":{"observed_intervention_modalities":["molecular-imaging-agent"],"observed_normalized_actions":["molecular-imaging"]},"basis_ids":["I-CTG-111in-in-dota-anti-cea-antibody-injection-db4657027f","I-CTG-iodine-i-123-anti-cea-recombinant-diabody--bd95c1eb88","I-CTG-radionuclide-imaging-4ddc489e17","I-CTG-sgm-101-3d31779152"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-molecular-imaging-route","job_id":"P-JOB-ACTION-T-ENSG00000105388-TADM-PJ-15-observed-imaging-route","rule_id":"TADM-PJ-15-observed-imaging-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-15-observed-imaging-route","TADM-PJ-18-observed-imaging-modality-route"]},{"basis":{"observed_intervention_modalities":["radioligand-therapy"],"observed_normalized_actions":[]},"basis_ids":["I-CTG-yttrium-y-90-dota-anti-cea-monoclonal-anti-961f658b9c"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-radionuclide-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000105388-TADM-PJ-19-observed-radioligand-modality-route","rule_id":"TADM-PJ-19-observed-radioligand-modality-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-19-observed-radioligand-modality-route"]}],"ranking":{"evidence_rank":5,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":1,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"molecular-imaging","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-sgm-101-3d31779152"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000105388","target_identity":{"gene_symbol":"CEACAM5","preferred_name":"CEACAM5","state":"observed-canonical-target-record","uniprot_accessions":["P06731"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"therapeutic-antibody-epitope":1},"partner_class_counts":{"therapeutic-antibody-fab":1},"pdb_ids":["1YY9"],"site_count":1,"site_ids":["SITE-RCSB-1YY9-cetuximab-fab"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"represented","deposited_site_relevance_states":{"target-level-not-site-localized":10},"distinct_reported_molecule_count":10,"measured_compound_record_count":10,"representative_interaction_ids":["KCI-BINDINGDB-45e84700f5818806","KCI-BINDINGDB-6208f22d1f1d6c16","KCI-BINDINGDB-8e6d653dad238487","KCI-BINDINGDB-9dd515e75e406f98","KCI-BINDINGDB-d0212c8a52918ef8"],"state":"observed-measured-compound-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":95,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":100.0,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":53,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"antagonist":2,"binder":3,"blocker":2,"cytotoxic-payload-delivery":2,"inhibitor":2},"action_representatives":[{"action":"antagonist","representative_intervention_ids":["I-CTG-cetuximab-22d728a3c3","I-CTG-panitumumab-b41fb4011c"],"state":"observed-intervention-action-association"},{"action":"binder","representative_intervention_ids":["I-CTG-cetuximab-22d728a3c3","I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"state":"observed-intervention-action-association"},{"action":"blocker","representative_intervention_ids":["I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"state":"observed-intervention-action-association"},{"action":"cytotoxic-payload-delivery","representative_intervention_ids":["I-CTG-ibi3028-ff981e0ea3","I-CTG-js212-0f8ea7a70b"],"state":"observed-intervention-action-association"},{"action":"inhibitor","representative_intervention_ids":["I-CTG-cetuximab-22d728a3c3","I-CTG-panitumumab-b41fb4011c"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":15,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody":8,"antibody-drug-conjugate":1,"bispecific-antibody":2,"bispecific-antibody-drug-conjugate":1,"conventional-cytotoxic-regimen":1,"molecular-imaging-agent":1,"radioligand-therapy":1},"registry_intervention_type_counts":{"BIOLOGICAL":2,"DRUG":11,"multiple":2},"representative_intervention_ids":["I-CTG-111in-fpi-2107-37ea0ec994","I-CTG-225ac-fpi-2068-86d75ffcc8","I-CTG-anti-egfr-containing-regimen-079e0c7097","I-CTG-anti-egfr-monoclonal-antibody-11294839cd","I-CTG-cetuximab-22d728a3c3"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"therapeutic-antibody-epitope","partner_class":"therapeutic-antibody-fab","partner_role":"therapeutic-binder","site_id":"SITE-RCSB-1YY9-cetuximab-fab"},"basis_ids":["SITE-RCSB-1YY9-cetuximab-fab","PDB:1YY9","I-CTG-cetuximab-22d728a3c3"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-1YY9-cetuximab-fab","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"},{"basis":{"observed_intervention_modalities":["molecular-imaging-agent"],"observed_normalized_actions":[]},"basis_ids":["I-CTG-111in-fpi-2107-37ea0ec994"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-molecular-imaging-route","job_id":"P-JOB-ACTION-T-ENSG00000146648-TADM-PJ-18-observed-imaging-modality-route","rule_id":"TADM-PJ-18-observed-imaging-modality-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-18-observed-imaging-modality-route"]},{"basis":{"observed_intervention_modalities":["antibody-drug-conjugate","bispecific-antibody-drug-conjugate"],"observed_normalized_actions":["cytotoxic-payload-delivery"]},"basis_ids":["I-CTG-ibi3028-ff981e0ea3","I-CTG-js212-0f8ea7a70b"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-payload-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000146648-TADM-PJ-16-observed-payload-route","rule_id":"TADM-PJ-16-observed-payload-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-16-observed-payload-route","TADM-PJ-20-observed-adc-modality-route","TADM-PJ-21-observed-bispecific-adc-modality-route"]},{"basis":{"observed_intervention_modalities":["radioligand-therapy"],"observed_normalized_actions":[]},"basis_ids":["I-CTG-225ac-fpi-2068-86d75ffcc8"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-radionuclide-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000146648-TADM-PJ-19-observed-radioligand-modality-route","rule_id":"TADM-PJ-19-observed-radioligand-modality-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-19-observed-radioligand-modality-route"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["antagonist"]},"basis_ids":["I-CTG-cetuximab-22d728a3c3","I-CTG-panitumumab-b41fb4011c"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-antagonism-after-site-and-assay-resolution","job_id":"P-JOB-ACTION-T-ENSG00000146648-TADM-PJ-11-observed-action-antagonist","rule_id":"TADM-PJ-11-observed-action-antagonist","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-11-observed-action-antagonist"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["binder"]},"basis_ids":["I-CTG-cetuximab-22d728a3c3","I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-binding-after-site-selection","job_id":"P-JOB-ACTION-T-ENSG00000146648-TADM-PJ-12-observed-action-binder","rule_id":"TADM-PJ-12-observed-action-binder","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-12-observed-action-binder"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["blocker"]},"basis_ids":["I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-blockade-after-partner-or-site-resolution","job_id":"P-JOB-ACTION-T-ENSG00000146648-TADM-PJ-13-observed-action-blocker","rule_id":"TADM-PJ-13-observed-action-blocker","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-13-observed-action-blocker"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["inhibitor"]},"basis_ids":["I-CTG-cetuximab-22d728a3c3","I-CTG-panitumumab-b41fb4011c"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-inhibition-after-site-and-assay-resolution","job_id":"P-JOB-ACTION-T-ENSG00000146648-TADM-PJ-14-observed-action-inhibitor","rule_id":"TADM-PJ-14-observed-action-inhibitor","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-14-observed-action-inhibitor"]}],"ranking":{"evidence_rank":16,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":2,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"antagonist","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-cetuximab-22d728a3c3","I-CTG-panitumumab-b41fb4011c"],"state":"observed-intervention-action-association"},{"action":"binder","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":3,"representative_intervention_ids":["I-CTG-cetuximab-22d728a3c3","I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"state":"observed-intervention-action-association"},{"action":"blocker","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"state":"observed-intervention-action-association"},{"action":"cytotoxic-payload-delivery","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-ibi3028-ff981e0ea3","I-CTG-js212-0f8ea7a70b"],"state":"observed-intervention-action-association"},{"action":"inhibitor","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-cetuximab-22d728a3c3","I-CTG-panitumumab-b41fb4011c"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000146648","target_identity":{"gene_symbol":"EGFR","preferred_name":"EGFR","state":"observed-canonical-target-record","uniprot_accessions":["P00533"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"therapeutic-antibody-epitope":1},"partner_class_counts":{"therapeutic-antibody-fab":1},"pdb_ids":["1N8Z"],"site_count":1,"site_ids":["SITE-RCSB-1N8Z-trastuzumab-fab"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"represented","deposited_site_relevance_states":{"pdb-indexed-target-match-not-site-localized":5,"target-level-not-site-localized":5},"distinct_reported_molecule_count":10,"measured_compound_record_count":10,"representative_interaction_ids":["KCI-BINDINGDB-105a0ec5c5afc361","KCI-BINDINGDB-1fa8c2e7dbcb2120","KCI-BINDINGDB-68892344b2bdbb35","KCI-BINDINGDB-76ea6126757b4230","KCI-BINDINGDB-ad246683fd17786d"],"state":"observed-measured-compound-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":95,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":100.0,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":92,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":68,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"binder":2,"cytotoxic-payload-delivery":2,"inhibitor":1,"molecular-imaging":2},"action_representatives":[{"action":"binder","representative_intervention_ids":["I-CTG-tqb2930-injection-oxaliplatin-injection-ca-64a50abf1a","I-CTG-tqb2930-injection-oxaliplatin-injection-ca-f14a3dfa1c"],"state":"observed-intervention-action-association"},{"action":"cytotoxic-payload-delivery","representative_intervention_ids":["I-CTG-a166-64561330f1","I-CTG-tqb2102-injection-fe523b8bde"],"state":"observed-intervention-action-association"},{"action":"inhibitor","representative_intervention_ids":["I-CTG-trastuzumab-672bb991dc"],"state":"observed-intervention-action-association"},{"action":"molecular-imaging","representative_intervention_ids":["I-CTG-18f-f-resca-rb14-b3e631ee50","I-CTG-68ga-ga-dota-h2d3-c90970f5a7"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":12,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody":2,"antibody-drug-conjugate":2,"bispecific-antibody":1,"car-t-cell-therapy":1,"conventional-cytotoxic-regimen":2,"molecular-imaging-agent":2,"other-or-unclear":1,"small-molecule":1},"registry_intervention_type_counts":{"BIOLOGICAL":2,"DRUG":7,"multiple":3},"representative_intervention_ids":["I-CTG-18f-f-resca-rb14-b3e631ee50","I-CTG-68ga-ga-dota-h2d3-c90970f5a7","I-CTG-a166-64561330f1","I-CTG-anti-her2-car-t-c75d83eaec","I-CTG-ct-0508-e0402d4074"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"therapeutic-antibody-epitope","partner_class":"therapeutic-antibody-fab","partner_role":"therapeutic-binder","site_id":"SITE-RCSB-1N8Z-trastuzumab-fab"},"basis_ids":["SITE-RCSB-1N8Z-trastuzumab-fab","PDB:1N8Z","I-CTG-trastuzumab-672bb991dc"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-1N8Z-trastuzumab-fab","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"},{"basis":{"observed_intervention_modalities":["molecular-imaging-agent"],"observed_normalized_actions":["molecular-imaging"]},"basis_ids":["I-CTG-18f-f-resca-rb14-b3e631ee50","I-CTG-68ga-ga-dota-h2d3-c90970f5a7"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-molecular-imaging-route","job_id":"P-JOB-ACTION-T-ENSG00000141736-TADM-PJ-15-observed-imaging-route","rule_id":"TADM-PJ-15-observed-imaging-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-15-observed-imaging-route","TADM-PJ-18-observed-imaging-modality-route"]},{"basis":{"observed_intervention_modalities":["antibody-drug-conjugate"],"observed_normalized_actions":["cytotoxic-payload-delivery"]},"basis_ids":["I-CTG-a166-64561330f1","I-CTG-tqb2102-injection-fe523b8bde"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-payload-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000141736-TADM-PJ-16-observed-payload-route","rule_id":"TADM-PJ-16-observed-payload-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-16-observed-payload-route","TADM-PJ-20-observed-adc-modality-route"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["binder"]},"basis_ids":["I-CTG-tqb2930-injection-oxaliplatin-injection-ca-64a50abf1a","I-CTG-tqb2930-injection-oxaliplatin-injection-ca-f14a3dfa1c"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-binding-after-site-selection","job_id":"P-JOB-ACTION-T-ENSG00000141736-TADM-PJ-12-observed-action-binder","rule_id":"TADM-PJ-12-observed-action-binder","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-12-observed-action-binder"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["inhibitor"]},"basis_ids":["I-CTG-trastuzumab-672bb991dc"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-inhibition-after-site-and-assay-resolution","job_id":"P-JOB-ACTION-T-ENSG00000141736-TADM-PJ-14-observed-action-inhibitor","rule_id":"TADM-PJ-14-observed-action-inhibitor","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-14-observed-action-inhibitor"]}],"ranking":{"evidence_rank":17,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":3,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"binder","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-tqb2930-injection-oxaliplatin-injection-ca-64a50abf1a","I-CTG-tqb2930-injection-oxaliplatin-injection-ca-f14a3dfa1c"],"state":"observed-intervention-action-association"},{"action":"cytotoxic-payload-delivery","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-a166-64561330f1","I-CTG-tqb2102-injection-fe523b8bde"],"state":"observed-intervention-action-association"},{"action":"inhibitor","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-trastuzumab-672bb991dc"],"state":"observed-intervention-action-association"},{"action":"molecular-imaging","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-18f-f-resca-rb14-b3e631ee50","I-CTG-68ga-ga-dota-h2d3-c90970f5a7"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000141736","target_identity":{"gene_symbol":"ERBB2","preferred_name":"ERBB2","state":"observed-canonical-target-record","uniprot_accessions":["P04626"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"experimental-antibody-fragment-epitope":1},"partner_class_counts":{"research-antibody-fragment":1},"pdb_ids":["6I07"],"site_count":1,"site_ids":["SITE-RCSB-6I07-epcam-binding-scfv"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"represented","deposited_site_relevance_states":{"target-level-not-site-localized":2},"distinct_reported_molecule_count":2,"measured_compound_record_count":2,"representative_interaction_ids":["KCI-BINDINGDB-5116757b4315b4d0","KCI-CHEMBL-26218781"],"state":"observed-measured-compound-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":95,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":92,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":90,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":82,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":23,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"car-t-cell-therapy":3},"registry_intervention_type_counts":{"BIOLOGICAL":2,"DRUG":1},"representative_intervention_ids":["I-CTG-car-t-cell-immunotherapy-1ef738f219","I-CTG-car-t-cells-targeting-epcam-552a0c6e28","I-CTG-epcam-car-t-6e829ef49b"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"experimental-antibody-fragment-epitope","partner_class":"research-antibody-fragment","partner_role":"research-binder","site_id":"SITE-RCSB-6I07-epcam-binding-scfv"},"basis_ids":["SITE-RCSB-6I07-epcam-binding-scfv","PDB:6I07"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-6I07-epcam-binding-scfv","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"}],"ranking":{"evidence_rank":2,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":4,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000119888","target_identity":{"gene_symbol":"EPCAM","preferred_name":"EPCAM","state":"observed-canonical-target-record","uniprot_accessions":["P16422"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"natural-partner-interface":1,"therapeutic-antibody-epitope":1},"partner_class_counts":{"natural-protein-partner":1,"therapeutic-antibody-fab":1},"pdb_ids":["4K3J"],"site_count":2,"site_ids":["SITE-RCSB-4K3J-hgf-beta-chain","SITE-RCSB-4K3J-onartuzumab-fab"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"represented","deposited_site_relevance_states":{"pdb-indexed-target-match-not-site-localized":5,"target-level-not-site-localized":5},"distinct_reported_molecule_count":10,"measured_compound_record_count":10,"representative_interaction_ids":["KCI-BINDINGDB-07b5180568b7a80a","KCI-BINDINGDB-086ad40138f8ffc9","KCI-BINDINGDB-7e6ba957e80bed5b","KCI-BINDINGDB-e5a7cd86571d5244","KCI-BINDINGDB-e5c5966f67a1df06"],"state":"observed-measured-compound-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":95,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":100.0,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":53,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"binder":2,"blocker":2,"cytotoxic-payload-delivery":1},"action_representatives":[{"action":"binder","representative_intervention_ids":["I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"state":"observed-intervention-action-association"},{"action":"blocker","representative_intervention_ids":["I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"state":"observed-intervention-action-association"},{"action":"cytotoxic-payload-delivery","representative_intervention_ids":["I-CTG-ibi3028-ff981e0ea3"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":6,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody-drug-conjugate":1,"bispecific-antibody":2,"molecular-imaging-agent":2,"radioligand-therapy":1},"registry_intervention_type_counts":{"DIAGNOSTIC_TEST":1,"DRUG":5},"representative_intervention_ids":["I-CTG-111in-fpi-2107-37ea0ec994","I-CTG-225ac-fpi-2068-86d75ffcc8","I-CTG-68ga-ga-fl-261-pet-imaging-111in-in-fl-261-1cd979f4ad","I-CTG-ibi3028-ff981e0ea3","I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"natural-partner-interface","partner_class":"natural-protein-partner","partner_role":"natural-partner","site_id":"SITE-RCSB-4K3J-hgf-beta-chain"},"basis_ids":["SITE-RCSB-4K3J-hgf-beta-chain","PDB:4K3J"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"compete-at-observed-natural-ligand-interface","job_id":"P-JOB-SITE-SITE-RCSB-4K3J-hgf-beta-chain","rule_id":"TADM-PJ-03-natural-ligand-interface","state":"proposed-site-conditioned-molecular-job"},{"basis":{"interaction_class":"therapeutic-antibody-epitope","partner_class":"therapeutic-antibody-fab","partner_role":"therapeutic-binder","site_id":"SITE-RCSB-4K3J-onartuzumab-fab"},"basis_ids":["SITE-RCSB-4K3J-onartuzumab-fab","PDB:4K3J"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-4K3J-onartuzumab-fab","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"},{"basis":{"observed_intervention_modalities":["molecular-imaging-agent"],"observed_normalized_actions":[]},"basis_ids":["I-CTG-111in-fpi-2107-37ea0ec994","I-CTG-68ga-ga-fl-261-pet-imaging-111in-in-fl-261-1cd979f4ad"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-molecular-imaging-route","job_id":"P-JOB-ACTION-T-ENSG00000105976-TADM-PJ-18-observed-imaging-modality-route","rule_id":"TADM-PJ-18-observed-imaging-modality-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-18-observed-imaging-modality-route"]},{"basis":{"observed_intervention_modalities":["antibody-drug-conjugate"],"observed_normalized_actions":["cytotoxic-payload-delivery"]},"basis_ids":["I-CTG-ibi3028-ff981e0ea3"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-payload-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000105976-TADM-PJ-16-observed-payload-route","rule_id":"TADM-PJ-16-observed-payload-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-16-observed-payload-route","TADM-PJ-20-observed-adc-modality-route"]},{"basis":{"observed_intervention_modalities":["radioligand-therapy"],"observed_normalized_actions":[]},"basis_ids":["I-CTG-225ac-fpi-2068-86d75ffcc8"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-radionuclide-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000105976-TADM-PJ-19-observed-radioligand-modality-route","rule_id":"TADM-PJ-19-observed-radioligand-modality-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-19-observed-radioligand-modality-route"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["binder"]},"basis_ids":["I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-binding-after-site-selection","job_id":"P-JOB-ACTION-T-ENSG00000105976-TADM-PJ-12-observed-action-binder","rule_id":"TADM-PJ-12-observed-action-binder","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-12-observed-action-binder"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["blocker"]},"basis_ids":["I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-blockade-after-partner-or-site-resolution","job_id":"P-JOB-ACTION-T-ENSG00000105976-TADM-PJ-13-observed-action-blocker","rule_id":"TADM-PJ-13-observed-action-blocker","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-13-observed-action-blocker"]}],"ranking":{"evidence_rank":23,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":5,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"binder","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"state":"observed-intervention-action-association"},{"action":"blocker","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-tqb2922-injection-tas-102-tablets-39aec93b5f","I-CTG-tqb2922-injection-tas-102-tablets-bevacizu-862724615d"],"state":"observed-intervention-action-association"},{"action":"cytotoxic-payload-delivery","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-ibi3028-ff981e0ea3"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000105976","target_identity":{"gene_symbol":"MET","preferred_name":"MET","state":"observed-canonical-target-record","uniprot_accessions":["P08581"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"therapeutic-antibody-epitope":1},"partner_class_counts":{"therapeutic-antibody-fab":1},"pdb_ids":["9PI9"],"site_count":1,"site_ids":["SITE-RCSB-9PI9-sacituzumab-fab"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"queried-no-selected-records","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"queried-no-selected-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":95,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":100.0,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":23,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"molecular-imaging":2},"action_representatives":[{"action":"molecular-imaging","representative_intervention_ids":["I-CTG-18f-f-resca-t4-35b147630c","I-CTG-68ga-ga-nota-t4-9e339e2328"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody-drug-conjugate":1,"molecular-imaging-agent":2},"registry_intervention_type_counts":{"DRUG":3},"representative_intervention_ids":["I-CTG-18f-f-resca-t4-35b147630c","I-CTG-68ga-ga-nota-t4-9e339e2328","I-CTG-datopotamab-deruxtecan-dato-dxd-90cdcc43e0"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","no-selected-measured-compound-records-in-bounded-source-coverage"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"therapeutic-antibody-epitope","partner_class":"therapeutic-antibody-fab","partner_role":"therapeutic-binder","site_id":"SITE-RCSB-9PI9-sacituzumab-fab"},"basis_ids":["SITE-RCSB-9PI9-sacituzumab-fab","PDB:9PI9"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-9PI9-sacituzumab-fab","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"},{"basis":{"observed_intervention_modalities":["molecular-imaging-agent"],"observed_normalized_actions":["molecular-imaging"]},"basis_ids":["I-CTG-18f-f-resca-t4-35b147630c","I-CTG-68ga-ga-nota-t4-9e339e2328"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-molecular-imaging-route","job_id":"P-JOB-ACTION-T-ENSG00000184292-TADM-PJ-15-observed-imaging-route","rule_id":"TADM-PJ-15-observed-imaging-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-15-observed-imaging-route","TADM-PJ-18-observed-imaging-modality-route"]},{"basis":{"observed_intervention_modalities":["antibody-drug-conjugate"],"observed_normalized_actions":[]},"basis_ids":["I-CTG-datopotamab-deruxtecan-dato-dxd-90cdcc43e0"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-payload-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000184292-TADM-PJ-20-observed-adc-modality-route","rule_id":"TADM-PJ-20-observed-adc-modality-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-20-observed-adc-modality-route"]}],"ranking":{"evidence_rank":33,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":6,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"molecular-imaging","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-18f-f-resca-t4-35b147630c","I-CTG-68ga-ga-nota-t4-9e339e2328"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000184292","target_identity":{"gene_symbol":"TACSTD2","preferred_name":"TACSTD2","state":"observed-canonical-target-record","uniprot_accessions":["P09758"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"experimental-antibody-fragment-epitope":1,"experimental-small-molecule-pocket":1},"partner_class_counts":{"research-antibody-fragment":1,"small-molecule":1},"pdb_ids":["7BBJ","9R0G"],"site_count":2,"site_ids":["SITE-RCSB-7BBJ-mab19-fab","SITE-RCSB-9R0G-cd73-compound-21"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"represented","deposited_site_relevance_states":{"target-level-not-site-localized":10},"distinct_reported_molecule_count":9,"measured_compound_record_count":10,"representative_interaction_ids":["KCI-BINDINGDB-28c1c93d467d5e41","KCI-BINDINGDB-29aeb14112f4c59d","KCI-BINDINGDB-4ca4e279a02ca5b9","KCI-BINDINGDB-737fe486bdd27f84","KCI-BINDINGDB-fb5a19e615ed96ca"],"state":"observed-measured-compound-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":100.0,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":98,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"inhibitor":1},"action_representatives":[{"action":"inhibitor","representative_intervention_ids":["I-CTG-ab680-d446c5ca53"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody":2,"small-molecule":1},"registry_intervention_type_counts":{"DRUG":3},"representative_intervention_ids":["I-CTG-ab680-d446c5ca53","I-CTG-cpi-006-7295548d5e","I-CTG-oleclumab-ad0acf4f20"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"experimental-antibody-fragment-epitope","partner_class":"research-antibody-fragment","partner_role":"research-binder","site_id":"SITE-RCSB-7BBJ-mab19-fab"},"basis_ids":["SITE-RCSB-7BBJ-mab19-fab","PDB:7BBJ"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-7BBJ-mab19-fab","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"},{"basis":{"interaction_class":"experimental-small-molecule-pocket","partner_class":"small-molecule","partner_role":"small-molecule-binder","site_id":"SITE-RCSB-9R0G-cd73-compound-21"},"basis_ids":["SITE-RCSB-9R0G-cd73-compound-21","PDB:9R0G"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"reproduce-or-compete-at-observed-deposited-small-molecule-pocket","job_id":"P-JOB-SITE-SITE-RCSB-9R0G-cd73-compound-21","rule_id":"TADM-PJ-01-deposited-small-molecule-pocket","state":"proposed-site-conditioned-molecular-job"},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["inhibitor"]},"basis_ids":["I-CTG-ab680-d446c5ca53"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-inhibition-after-site-and-assay-resolution","job_id":"P-JOB-ACTION-T-ENSG00000135318-TADM-PJ-14-observed-action-inhibitor","rule_id":"TADM-PJ-14-observed-action-inhibitor","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-14-observed-action-inhibitor"]}],"ranking":{"evidence_rank":31,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":7,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"inhibitor","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-ab680-d446c5ca53"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000135318","target_identity":{"gene_symbol":"NT5E","preferred_name":"NT5E","state":"observed-canonical-target-record","uniprot_accessions":["P21589"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"experimental-antibody-fragment-epitope":1},"partner_class_counts":{"research-antibody-fragment":1},"pdb_ids":["8GHP"],"site_count":1,"site_ids":["SITE-RCSB-8GHP-anti-gucy2c-scfv"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"queried-no-selected-records","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"queried-no-selected-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":90,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":92,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":53,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":4,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"car-nk-cell-therapy":2,"car-t-cell-therapy":2},"registry_intervention_type_counts":{"BIOLOGICAL":2,"DRUG":2},"representative_intervention_ids":["I-CTG-chimeric-antigen-receptor-t-cell-preparati-2461b7b2f2","I-CTG-eb-duo-car-nk-cea-gcc-9ddb5588c2","I-CTG-eb-duo-car-nk-cea-gcc-iv-ea153d70da","I-CTG-im96-car-t-cells-111524d9e1"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","no-selected-measured-compound-records-in-bounded-source-coverage"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"experimental-antibody-fragment-epitope","partner_class":"research-antibody-fragment","partner_role":"research-binder","site_id":"SITE-RCSB-8GHP-anti-gucy2c-scfv"},"basis_ids":["SITE-RCSB-8GHP-anti-gucy2c-scfv","PDB:8GHP"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-8GHP-anti-gucy2c-scfv","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"}],"ranking":{"evidence_rank":133,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":8,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000070019","target_identity":{"gene_symbol":"GUCY2C","preferred_name":"GUCY2C","state":"observed-canonical-target-record","uniprot_accessions":["P25092"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"experimental-nanobody-interface":1,"experimental-small-molecule-pocket":1},"partner_class_counts":{"nanobody-or-vhh":1,"small-molecule":1},"pdb_ids":["6Y0F","9DVR"],"site_count":2,"site_ids":["SITE-RCSB-6Y0F-linagliptin","SITE-RCSB-9DVR-sumo-i3-vhh-fusion"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"represented","deposited_site_relevance_states":{"pdb-indexed-target-match-not-site-localized":5,"target-level-not-site-localized":5},"distinct_reported_molecule_count":10,"measured_compound_record_count":10,"representative_interaction_ids":["KCI-BINDINGDB-0ac9eba24bfde384","KCI-BINDINGDB-8a02e58de3e24193","KCI-BINDINGDB-de51191c2a73a9a3","KCI-BINDINGDB-e89a96026ae4d4d1","KCI-BINDINGDB-fad46cd8f75e9711"],"state":"observed-measured-compound-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":90,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":83,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"experimental-small-molecule-pocket","partner_class":"small-molecule","partner_role":"small-molecule-inhibitor","site_id":"SITE-RCSB-6Y0F-linagliptin"},"basis_ids":["SITE-RCSB-6Y0F-linagliptin","PDB:6Y0F"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"reproduce-or-compete-at-observed-deposited-inhibitor-pocket","job_id":"P-JOB-SITE-SITE-RCSB-6Y0F-linagliptin","rule_id":"TADM-PJ-01-deposited-small-molecule-pocket","state":"proposed-site-conditioned-molecular-job"},{"basis":{"interaction_class":"experimental-nanobody-interface","partner_class":"nanobody-or-vhh","partner_role":"research-binder","site_id":"SITE-RCSB-9DVR-sumo-i3-vhh-fusion"},"basis_ids":["SITE-RCSB-9DVR-sumo-i3-vhh-fusion","PDB:9DVR"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-9DVR-sumo-i3-vhh-fusion","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"}],"ranking":{"evidence_rank":150,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":9,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000078098","target_identity":{"gene_symbol":"FAP","preferred_name":"FAP","state":"observed-canonical-target-record","uniprot_accessions":["Q12884"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":null,"coverage_state":"derived-deposited-site","interaction_class_counts":{"natural-partner-interface":1},"partner_class_counts":{"natural-protein-partner":1},"pdb_ids":["2JJS"],"site_count":1,"site_ids":["SITE-RCSB-2JJS-sirp-alpha-extracellular-domain"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"represented","deposited_site_relevance_states":{"target-level-not-site-localized":5},"distinct_reported_molecule_count":5,"measured_compound_record_count":5,"representative_interaction_ids":["KCI-CHEMBL-16668997","KCI-CHEMBL-16668998","KCI-CHEMBL-16668999","KCI-CHEMBL-16669000","KCI-CHEMBL-19306596"],"state":"observed-measured-compound-records"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":23,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"natural-partner-interface","partner_class":"natural-protein-partner","partner_role":"natural-partner","site_id":"SITE-RCSB-2JJS-sirp-alpha-extracellular-domain"},"basis_ids":["SITE-RCSB-2JJS-sirp-alpha-extracellular-domain","PDB:2JJS"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"block-observed-immune-receptor-partner-interface","job_id":"P-JOB-SITE-SITE-RCSB-2JJS-sirp-alpha-extracellular-domain","rule_id":"TADM-PJ-02-immune-receptor-partner-interface","state":"proposed-site-conditioned-molecular-job"}],"ranking":{"evidence_rank":55,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":10,"structure_tier":"structure-a"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000196776","target_identity":{"gene_symbol":"CD47","preferred_name":"CD47","state":"observed-canonical-target-record","uniprot_accessions":["Q08722"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"The deposited 8TCG control supplies a prepared reference interface; broader structure-b site enumeration was not evaluated in this demo tier.","coverage_state":"supplemental-prepared-site-available","interaction_class_counts":{"experimental-reference-miniprotein-interface":1},"partner_class_counts":{"miniprotein":1},"pdb_ids":["8TCG"],"site_count":1,"site_ids":["SITE-RCSB-8TCG-b6-bp-dslf-miniprotein"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":95,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":23,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"experimental-reference-miniprotein-interface","partner_class":"miniprotein","partner_role":"research-binder","site_id":"SITE-RCSB-8TCG-b6-bp-dslf-miniprotein"},"basis_ids":["SITE-RCSB-8TCG-b6-bp-dslf-miniprotein","PDB:8TCG"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-8TCG-b6-bp-dslf-miniprotein","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"}],"ranking":{"evidence_rank":35,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":11,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000115221","target_identity":{"gene_symbol":"ITGB6","preferred_name":"ITGB6","state":"observed-canonical-target-record","uniprot_accessions":["P18564"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"The deposited 8TCG control supplies a prepared reference interface; broader structure-b site enumeration was not evaluated in this demo tier.","coverage_state":"supplemental-prepared-site-available","interaction_class_counts":{"experimental-reference-miniprotein-interface":1},"partner_class_counts":{"miniprotein":1},"pdb_ids":["8TCG"],"site_count":1,"site_ids":["SITE-RCSB-8TCG-b6-bp-dslf-miniprotein"],"state":"observed-deposited-sites"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":95,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":23,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"interaction_class":"experimental-reference-miniprotein-interface","partner_class":"miniprotein","partner_role":"research-binder","site_id":"SITE-RCSB-8TCG-b6-bp-dslf-miniprotein"},"basis_ids":["SITE-RCSB-8TCG-b6-bp-dslf-miniprotein","PDB:8TCG"],"claim_ceiling":"proposed experiment conditioned on observed deposited contact geometry; it does not establish activity, extracellular accessibility, affinity, selectivity, efficacy, safety, or a candidate","job":"bind-or-occupy-observed-deposited-epitope","job_id":"P-JOB-SITE-SITE-RCSB-8TCG-b6-bp-dslf-miniprotein","rule_id":"TADM-PJ-05-deposited-binder-epitope","state":"proposed-site-conditioned-molecular-job"}],"ranking":{"evidence_rank":48,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":12,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000138448","target_identity":{"gene_symbol":"ITGAV","preferred_name":"ITGAV","state":"observed-canonical-target-record","uniprot_accessions":["P06756"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":77,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":53,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000139292"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000139292","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":111,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":13,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000139292","target_identity":{"gene_symbol":"LGR5","preferred_name":"LGR5","state":"observed-canonical-target-record","uniprot_accessions":["O75473"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":92,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":90,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":82,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":23,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"car-t-cell-therapy":3},"registry_intervention_type_counts":{"BIOLOGICAL":3},"representative_intervention_ids":["I-CTG-cdh17-car-t-5fafb7c24d","I-CTG-chm-2101-car-t-cells-1f528dedbe","I-CTG-fast-laco-stim-cdh17-car-t-41ef783a2e"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000079112"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000079112","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":14,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":14,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000079112","target_identity":{"gene_symbol":"CDH17","preferred_name":"CDH17","state":"observed-canonical-target-record","uniprot_accessions":["Q12864"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"binder":3,"blocker":2,"inhibitor":4},"action_representatives":[{"action":"binder","representative_intervention_ids":["I-CTG-keytruda-8266394dac","I-CTG-nivolumab-af64a27aa2","I-CTG-pembrolizumab-d8acadde7d"],"state":"observed-intervention-action-association"},{"action":"blocker","representative_intervention_ids":["I-CTG-keytruda-8266394dac","I-CTG-nivolumab-af64a27aa2"],"state":"observed-intervention-action-association"},{"action":"inhibitor","representative_intervention_ids":["I-CTG-nivolumab-af64a27aa2","I-CTG-pembrolizumab-d8acadde7d","I-CTG-sintilimab-mfolfox6-or-folfiri-bevacizumab-6e665e903a","I-CTG-tislelizumab-45f8cec74e"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":19,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody":13,"bispecific-antibody":2,"conventional-cytotoxic-regimen":2,"other-or-unclear":2},"registry_intervention_type_counts":{"BIOLOGICAL":3,"COMBINATION_PRODUCT":1,"DRUG":10,"OTHER":1,"multiple":4},"representative_intervention_ids":["I-CTG-anti-pd-1-antibody-0f75f0b392","I-CTG-anti-pd-1-monoclonal-antibody-83ef48eab2","I-CTG-balstilimab-5a47b9bd23","I-CTG-cemiplimab-fianlimab-fixed-dose-combinatio-2883943204","I-CTG-favezelimab-pembrolizumab-4da1038787"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["binder"]},"basis_ids":["I-CTG-keytruda-8266394dac","I-CTG-nivolumab-af64a27aa2","I-CTG-pembrolizumab-d8acadde7d"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-binding-after-site-selection","job_id":"P-JOB-ACTION-T-ENSG00000188389-TADM-PJ-12-observed-action-binder","rule_id":"TADM-PJ-12-observed-action-binder","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-12-observed-action-binder"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["blocker"]},"basis_ids":["I-CTG-keytruda-8266394dac","I-CTG-nivolumab-af64a27aa2"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-blockade-after-partner-or-site-resolution","job_id":"P-JOB-ACTION-T-ENSG00000188389-TADM-PJ-13-observed-action-blocker","rule_id":"TADM-PJ-13-observed-action-blocker","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-13-observed-action-blocker"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["inhibitor"]},"basis_ids":["I-CTG-nivolumab-af64a27aa2","I-CTG-pembrolizumab-d8acadde7d","I-CTG-sintilimab-mfolfox6-or-folfiri-bevacizumab-6e665e903a","I-CTG-tislelizumab-45f8cec74e"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-inhibition-after-site-and-assay-resolution","job_id":"P-JOB-ACTION-T-ENSG00000188389-TADM-PJ-14-observed-action-inhibitor","rule_id":"TADM-PJ-14-observed-action-inhibitor","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-14-observed-action-inhibitor"]}],"ranking":{"evidence_rank":98,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":15,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"binder","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":3,"representative_intervention_ids":["I-CTG-keytruda-8266394dac","I-CTG-nivolumab-af64a27aa2","I-CTG-pembrolizumab-d8acadde7d"],"state":"observed-intervention-action-association"},{"action":"blocker","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-keytruda-8266394dac","I-CTG-nivolumab-af64a27aa2"],"state":"observed-intervention-action-association"},{"action":"inhibitor","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":4,"representative_intervention_ids":["I-CTG-nivolumab-af64a27aa2","I-CTG-pembrolizumab-d8acadde7d","I-CTG-sintilimab-mfolfox6-or-folfiri-bevacizumab-6e665e903a","I-CTG-tislelizumab-45f8cec74e"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000188389","target_identity":{"gene_symbol":"PDCD1","preferred_name":"PDCD1","state":"observed-canonical-target-record","uniprot_accessions":["Q15116"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"molecular-imaging":2},"action_representatives":[{"action":"molecular-imaging","representative_intervention_ids":["I-CTG-18f-f-resca-wwh347-2c82aa5ec4","I-CTG-68ga-ga-nota-wwh347-6c428e5c54"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"molecular-imaging-agent":3},"registry_intervention_type_counts":{"DRUG":3},"representative_intervention_ids":["I-CTG-18f-f-resca-wwh347-2c82aa5ec4","I-CTG-68ga-ga-nota-wwh347-6c428e5c54","I-CTG-iodine-124-labeled-humanized-a33-antibody-e8caa6e23e"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"observed_intervention_modalities":["molecular-imaging-agent"],"observed_normalized_actions":["molecular-imaging"]},"basis_ids":["I-CTG-18f-f-resca-wwh347-2c82aa5ec4","I-CTG-68ga-ga-nota-wwh347-6c428e5c54","I-CTG-iodine-124-labeled-humanized-a33-antibody-e8caa6e23e"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-molecular-imaging-route","job_id":"P-JOB-ACTION-T-ENSG00000143167-TADM-PJ-15-observed-imaging-route","rule_id":"TADM-PJ-15-observed-imaging-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-15-observed-imaging-route","TADM-PJ-18-observed-imaging-modality-route"]}],"ranking":{"evidence_rank":15,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":16,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"molecular-imaging","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-18f-f-resca-wwh347-2c82aa5ec4","I-CTG-68ga-ga-nota-wwh347-6c428e5c54"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000143167","target_identity":{"gene_symbol":"GPA33","preferred_name":"GPA33","state":"observed-canonical-target-record","uniprot_accessions":["Q99795"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":87,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":2,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"car-nk-cell-therapy":1,"car-t-cell-therapy":1},"registry_intervention_type_counts":{"BIOLOGICAL":2},"representative_intervention_ids":["I-CTG-anti-muc1-car-pnk-cells-ec10721779","I-CTG-anti-muc1-car-t-cells-7dae37eda8"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000185499"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000185499","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":13,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":17,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000185499","target_identity":{"gene_symbol":"MUC1","preferred_name":"MUC1","state":"observed-canonical-target-record","uniprot_accessions":["P15941"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"binder":3,"blocker":3,"inhibitor":1},"action_representatives":[{"action":"binder","representative_intervention_ids":["I-CTG-atezolizumab-5dd1e8658b","I-CTG-avelumab-b59aea15d3","I-CTG-durvalumab-a8c0108ba9"],"state":"observed-intervention-action-association"},{"action":"blocker","representative_intervention_ids":["I-CTG-atezolizumab-5dd1e8658b","I-CTG-avelumab-b59aea15d3","I-CTG-durvalumab-a8c0108ba9"],"state":"observed-intervention-action-association"},{"action":"inhibitor","representative_intervention_ids":["I-CTG-atezolizumab-5dd1e8658b"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":4,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody":4},"registry_intervention_type_counts":{"DRUG":1,"multiple":3},"representative_intervention_ids":["I-CTG-anti-pd-l1-monoclonal-antibody-b15c504477","I-CTG-atezolizumab-5dd1e8658b","I-CTG-avelumab-b59aea15d3","I-CTG-durvalumab-a8c0108ba9"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["binder"]},"basis_ids":["I-CTG-atezolizumab-5dd1e8658b","I-CTG-avelumab-b59aea15d3","I-CTG-durvalumab-a8c0108ba9"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-binding-after-site-selection","job_id":"P-JOB-ACTION-T-ENSG00000120217-TADM-PJ-12-observed-action-binder","rule_id":"TADM-PJ-12-observed-action-binder","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-12-observed-action-binder"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["blocker"]},"basis_ids":["I-CTG-atezolizumab-5dd1e8658b","I-CTG-avelumab-b59aea15d3","I-CTG-durvalumab-a8c0108ba9"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-blockade-after-partner-or-site-resolution","job_id":"P-JOB-ACTION-T-ENSG00000120217-TADM-PJ-13-observed-action-blocker","rule_id":"TADM-PJ-13-observed-action-blocker","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-13-observed-action-blocker"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["inhibitor"]},"basis_ids":["I-CTG-atezolizumab-5dd1e8658b"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-inhibition-after-site-and-assay-resolution","job_id":"P-JOB-ACTION-T-ENSG00000120217-TADM-PJ-14-observed-action-inhibitor","rule_id":"TADM-PJ-14-observed-action-inhibitor","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-14-observed-action-inhibitor"]}],"ranking":{"evidence_rank":62,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":18,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"binder","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":3,"representative_intervention_ids":["I-CTG-atezolizumab-5dd1e8658b","I-CTG-avelumab-b59aea15d3","I-CTG-durvalumab-a8c0108ba9"],"state":"observed-intervention-action-association"},{"action":"blocker","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":3,"representative_intervention_ids":["I-CTG-atezolizumab-5dd1e8658b","I-CTG-avelumab-b59aea15d3","I-CTG-durvalumab-a8c0108ba9"],"state":"observed-intervention-action-association"},{"action":"inhibitor","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-atezolizumab-5dd1e8658b"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000120217","target_identity":{"gene_symbol":"CD274","preferred_name":"CD274","state":"observed-canonical-target-record","uniprot_accessions":["Q9NZQ7"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":87,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"car-t-cell-therapy":3},"registry_intervention_type_counts":{"BIOLOGICAL":2,"DRUG":1},"representative_intervention_ids":["I-CTG-car-t-cells-c5bd1845e7","I-CTG-kt032-anti-msln-chimeric-antigen-receptor--6cffa98224","I-CTG-pd1-msln-car-t-cells-2d2d907322"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000102854"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000102854","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":19,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":19,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000102854","target_identity":{"gene_symbol":"MSLN","preferred_name":"MSLN","state":"observed-canonical-target-record","uniprot_accessions":["Q13421"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000086548"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000086548","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":1,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":20,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000086548","target_identity":{"gene_symbol":"CEACAM6","preferred_name":"CEACAM6","state":"observed-canonical-target-record","uniprot_accessions":["P40199"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":63,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"antagonist":1,"binder":1,"blocker":1,"inhibitor":2},"action_representatives":[{"action":"antagonist","representative_intervention_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c"],"state":"observed-intervention-action-association"},{"action":"binder","representative_intervention_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c"],"state":"observed-intervention-action-association"},{"action":"blocker","representative_intervention_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c"],"state":"observed-intervention-action-association"},{"action":"inhibitor","representative_intervention_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c","I-CTG-regorafenib-9aec6927fe"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody":2,"small-molecule":1},"registry_intervention_type_counts":{"DRUG":3},"representative_intervention_ids":["I-CTG-ramucirumab-3e3bf3aa35","I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c","I-CTG-regorafenib-9aec6927fe"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["antagonist"]},"basis_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-antagonism-after-site-and-assay-resolution","job_id":"P-JOB-ACTION-T-ENSG00000128052-TADM-PJ-11-observed-action-antagonist","rule_id":"TADM-PJ-11-observed-action-antagonist","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-11-observed-action-antagonist"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["binder"]},"basis_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-binding-after-site-selection","job_id":"P-JOB-ACTION-T-ENSG00000128052-TADM-PJ-12-observed-action-binder","rule_id":"TADM-PJ-12-observed-action-binder","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-12-observed-action-binder"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["blocker"]},"basis_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-blockade-after-partner-or-site-resolution","job_id":"P-JOB-ACTION-T-ENSG00000128052-TADM-PJ-13-observed-action-blocker","rule_id":"TADM-PJ-13-observed-action-blocker","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-13-observed-action-blocker"]},{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["inhibitor"]},"basis_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c","I-CTG-regorafenib-9aec6927fe"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-inhibition-after-site-and-assay-resolution","job_id":"P-JOB-ACTION-T-ENSG00000128052-TADM-PJ-14-observed-action-inhibitor","rule_id":"TADM-PJ-14-observed-action-inhibitor","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-14-observed-action-inhibitor"]}],"ranking":{"evidence_rank":85,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":21,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"antagonist","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c"],"state":"observed-intervention-action-association"},{"action":"binder","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c"],"state":"observed-intervention-action-association"},{"action":"blocker","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c"],"state":"observed-intervention-action-association"},{"action":"inhibitor","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":2,"representative_intervention_ids":["I-CTG-ramucirumab-injection-cyramza-f05ac3bf5c","I-CTG-regorafenib-9aec6927fe"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000128052","target_identity":{"gene_symbol":"KDR","preferred_name":"KDR","state":"observed-canonical-target-record","uniprot_accessions":["P35968"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000173702"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000173702","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":9,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":22,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000173702","target_identity":{"gene_symbol":"MUC13","preferred_name":"MUC13","state":"observed-canonical-target-record","uniprot_accessions":["Q9H3R2"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"cytotoxic-payload-delivery":1},"action_representatives":[{"action":"cytotoxic-payload-delivery","representative_intervention_ids":["I-CTG-js212-0f8ea7a70b"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":1,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"bispecific-antibody-drug-conjugate":1},"registry_intervention_type_counts":{"DRUG":1},"representative_intervention_ids":["I-CTG-js212-0f8ea7a70b"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"observed_intervention_modalities":["bispecific-antibody-drug-conjugate"],"observed_normalized_actions":["cytotoxic-payload-delivery"]},"basis_ids":["I-CTG-js212-0f8ea7a70b"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-payload-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000065361-TADM-PJ-16-observed-payload-route","rule_id":"TADM-PJ-16-observed-payload-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-16-observed-payload-route","TADM-PJ-21-observed-bispecific-adc-modality-route"]}],"ranking":{"evidence_rank":18,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":23,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"cytotoxic-payload-delivery","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-js212-0f8ea7a70b"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000065361","target_identity":{"gene_symbol":"ERBB3","preferred_name":"ERBB3","state":"observed-canonical-target-record","uniprot_accessions":["P21860"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000011422"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000011422","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":71,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":24,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000011422","target_identity":{"gene_symbol":"PLAUR","preferred_name":"PLAUR","state":"observed-canonical-target-record","uniprot_accessions":["Q03405"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000189143"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000189143","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":7,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":25,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000189143","target_identity":{"gene_symbol":"CLDN4","preferred_name":"CLDN4","state":"observed-canonical-target-record","uniprot_accessions":["O14493"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000133216"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000133216","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":10,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":26,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000133216","target_identity":{"gene_symbol":"EPHB2","preferred_name":"EPHB2","state":"observed-canonical-target-record","uniprot_accessions":["P29323"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{"binder":1},"action_representatives":[{"action":"binder","representative_intervention_ids":["I-CTG-amg-479-f079f70775"],"state":"observed-intervention-action-association"}],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody":3},"registry_intervention_type_counts":{"BIOLOGICAL":3},"representative_intervention_ids":["I-CTG-amg-479-f079f70775","I-CTG-cp-751-871-7112346d32","I-CTG-ganitumab-5365bed8a8"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"observed_intervention_modalities":[],"observed_normalized_actions":["binder"]},"basis_ids":["I-CTG-amg-479-f079f70775"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"test-target-associated-binding-after-site-selection","job_id":"P-JOB-ACTION-T-ENSG00000140443-TADM-PJ-12-observed-action-binder","rule_id":"TADM-PJ-12-observed-action-binder","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-12-observed-action-binder"]}],"ranking":{"evidence_rank":107,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":27,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"binder","claim_ceiling":"association from an assigned intervention record; not a target-specific extracellular mechanism or efficacy conclusion","intervention_count":1,"representative_intervention_ids":["I-CTG-amg-479-f079f70775"],"state":"observed-intervention-action-association"}],"target_id":"T-ENSG00000140443","target_identity":{"gene_symbol":"IGF1R","preferred_name":"IGF1R","state":"observed-canonical-target-record","uniprot_accessions":["P08069"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000165215"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000165215","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":3,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":28,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000165215","target_identity":{"gene_symbol":"CLDN3","preferred_name":"CLDN3","state":"observed-canonical-target-record","uniprot_accessions":["O15551"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000181885"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000181885","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":4,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":29,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000181885","target_identity":{"gene_symbol":"CLDN7","preferred_name":"CLDN7","state":"observed-canonical-target-record","uniprot_accessions":["O95471"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-b target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000149294"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000149294","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":93,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":30,"structure_tier":"structure-b"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000149294","target_identity":{"gene_symbol":"NCAM1","preferred_name":"NCAM1","state":"observed-canonical-target-record","uniprot_accessions":["P13591"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000127324"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000127324","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":6,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":31,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000127324","target_identity":{"gene_symbol":"TSPAN8","preferred_name":"TSPAN8","state":"observed-canonical-target-record","uniprot_accessions":["P19075"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":87,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000066405"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000066405","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":102,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":32,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000066405","target_identity":{"gene_symbol":"CLDN18","preferred_name":"CLDN18","state":"observed-canonical-target-record","uniprot_accessions":["P56856"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody-drug-conjugate":3},"registry_intervention_type_counts":{"BIOLOGICAL":3},"representative_intervention_ids":["I-CTG-vobramitamab-duocarmazine-2-0-mg-arm-a-070889dad2","I-CTG-vobramitamab-duocarmazine-2-7-mg-arm-b-61467fa51b","I-CTG-vobramitamab-duocarmazine-50a4e37d35"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"observed_intervention_modalities":["antibody-drug-conjugate"],"observed_normalized_actions":[]},"basis_ids":["I-CTG-vobramitamab-duocarmazine-2-0-mg-arm-a-070889dad2","I-CTG-vobramitamab-duocarmazine-2-7-mg-arm-b-61467fa51b","I-CTG-vobramitamab-duocarmazine-50a4e37d35"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-payload-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000103855-TADM-PJ-20-observed-adc-modality-route","rule_id":"TADM-PJ-20-observed-adc-modality-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-20-observed-adc-modality-route"]}],"ranking":{"evidence_rank":51,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":33,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000103855","target_identity":{"gene_symbol":"CD276","preferred_name":"CD276","state":"observed-canonical-target-record","uniprot_accessions":["Q5ZPR3"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000039068"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000039068","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":8,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":34,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000039068","target_identity":{"gene_symbol":"CDH1","preferred_name":"CDH1","state":"observed-canonical-target-record","uniprot_accessions":["P12830"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000204580"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000204580","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":29,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":35,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000204580","target_identity":{"gene_symbol":"DDR1","preferred_name":"DDR1","state":"observed-canonical-target-record","uniprot_accessions":["Q08345"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000151694"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000151694","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":158,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":36,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000151694","target_identity":{"gene_symbol":"ADAM17","preferred_name":"ADAM17","state":"observed-canonical-target-record","uniprot_accessions":["P78536"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000163347"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000163347","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":20,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":37,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000163347","target_identity":{"gene_symbol":"CLDN1","preferred_name":"CLDN1","state":"observed-canonical-target-record","uniprot_accessions":["O95832"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000146242"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000146242","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":95,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":38,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000146242","target_identity":{"gene_symbol":"TPBG","preferred_name":"TPBG","state":"observed-canonical-target-record","uniprot_accessions":["Q13641"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":85,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":3,"claim_ceiling":"assigned intervention records and their normalized registry labels; a target association does not establish target-specific mechanism, extracellular site engagement, approval, efficacy, selectivity, or patient benefit","modality_counts":{"antibody":1,"molecular-imaging-agent":1,"radioligand-therapy":1},"registry_intervention_type_counts":{"BIOLOGICAL":1,"DRUG":2},"representative_intervention_ids":["I-CTG-111in-fpi-1967-89b7f5ed6d","I-CTG-225ac-fpi-1966-e299fbd736","I-CTG-vofatamab-eb0c930491"],"state":"observed-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":{"observed_intervention_modalities":["molecular-imaging-agent"],"observed_normalized_actions":[]},"basis_ids":["I-CTG-111in-fpi-1967-89b7f5ed6d"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-molecular-imaging-route","job_id":"P-JOB-ACTION-T-ENSG00000068078-TADM-PJ-18-observed-imaging-modality-route","rule_id":"TADM-PJ-18-observed-imaging-modality-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-18-observed-imaging-modality-route"]},{"basis":{"observed_intervention_modalities":["radioligand-therapy"],"observed_normalized_actions":[]},"basis_ids":["I-CTG-225ac-fpi-1966-e299fbd736"],"claim_ceiling":"proposal routed from an assigned intervention label; it does not establish a target-specific mechanism, extracellular site localization, activity, approval, efficacy, selectivity, safety, or a candidate","job":"evaluate-target-associated-radionuclide-delivery-route","job_id":"P-JOB-ACTION-T-ENSG00000068078-TADM-PJ-19-observed-radioligand-modality-route","rule_id":"TADM-PJ-19-observed-radioligand-modality-route","state":"proposed-observed-intervention-route","supporting_rule_ids":["TADM-PJ-19-observed-radioligand-modality-route"]}],"ranking":{"evidence_rank":141,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":39,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000068078","target_identity":{"gene_symbol":"FGFR3","preferred_name":"FGFR3","state":"observed-canonical-target-record","uniprot_accessions":["P22607"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000137845"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000137845","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":67,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":40,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000137845","target_identity":{"gene_symbol":"ADAM10","preferred_name":"ADAM10","state":"observed-canonical-target-record","uniprot_accessions":["O14672"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000149418"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000149418","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":11,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":41,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000149418","target_identity":{"gene_symbol":"ST14","preferred_name":"ST14","state":"observed-canonical-target-record","uniprot_accessions":["Q9Y5Y6"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000157227"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000157227","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":83,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":42,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000157227","target_identity":{"gene_symbol":"MMP14","preferred_name":"MMP14","state":"observed-canonical-target-record","uniprot_accessions":["P50281"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":80,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":72,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000108375"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000108375","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":12,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":43,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000108375","target_identity":{"gene_symbol":"RNF43","preferred_name":"RNF43","state":"observed-canonical-target-record","uniprot_accessions":["Q68DV7"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000138185"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000138185","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":38,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":44,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000138185","target_identity":{"gene_symbol":"ENTPD1","preferred_name":"ENTPD1","state":"observed-canonical-target-record","uniprot_accessions":["P49961"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000169604"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000169604","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":149,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":45,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000169604","target_identity":{"gene_symbol":"ANTXR1","preferred_name":"ANTXR1","state":"observed-canonical-target-record","uniprot_accessions":["Q9H6X2"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000142627"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000142627","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":65,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":46,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000142627","target_identity":{"gene_symbol":"EPHA2","preferred_name":"EPHA2","state":"observed-canonical-target-record","uniprot_accessions":["P29317"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000102755"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000102755","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":154,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":47,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000102755","target_identity":{"gene_symbol":"FLT1","preferred_name":"FLT1","state":"observed-canonical-target-record","uniprot_accessions":["P17948"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":18,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-routing-remains-provisional-transcript-context","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000106991"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000106991","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":146,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":48,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000106991","target_identity":{"gene_symbol":"ENG","preferred_name":"ENG","state":"observed-canonical-target-record","uniprot_accessions":["P17813"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000107159"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000107159","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":159,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":49,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000107159","target_identity":{"gene_symbol":"CA9","preferred_name":"CA9","state":"observed-canonical-target-record","uniprot_accessions":["Q16790"]}},{"deposited_sites_and_partner_classes":{"claim_ceiling":"site IDs and partner classes describe deposited contact geometry only; absence of a row is not a negative site conclusion and no site implies accessibility, action, affinity, selectivity, or efficacy","coverage_limitation":"This bounded Structure-A compiler did not evaluate deposited contact geometry for this structure-c target. The target remains in the census without a positive or negative site conclusion.","coverage_state":"not-evaluated-in-this-demo-tier","interaction_class_counts":{},"partner_class_counts":{},"pdb_ids":[],"site_count":0,"site_ids":[],"state":"not-evaluated-in-this-demo-tier"},"measured_compounds":{"claim_ceiling":"bounded measured compound records at target level; records do not establish extracellular deposited-site occupancy, surface accessibility, selectivity, therapeutic action, or efficacy","coverage_state":"not-measured","deposited_site_relevance_states":{},"distinct_reported_molecule_count":0,"measured_compound_record_count":0,"representative_interaction_ids":[],"state":"not-measured"},"modality_lanes":[{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-drug-conjugate","score":65,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"antibody-format-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"engineered-cell-therapy","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"miniprotein-binder","score":75,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"peptide-or-modified-peptide","score":67,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"radioligand-or-radioimmunotherapy","score":55,"state":"proposed-planning-fit"},{"claim_ceiling":"planning fit only; not a recommendation, mechanism, candidate, promotion, approval, efficacy, or selectivity claim","evidence_class":"planning-fit","maximum":100,"modality":"small-molecule","score":48,"state":"proposed-planning-fit"}],"normalized_intervention_actions":{"action_counts":{},"action_representatives":[],"assigned_intervention_count":0,"claim_ceiling":"no assigned intervention records in this collection; not evidence of no intervention or no actionable mechanism","modality_counts":{},"registry_intervention_type_counts":{},"representative_intervention_ids":[],"state":"not-measured-no-assigned-intervention-records"},"program_state":{"blocker_codes":["action-unresolved-in-assigned-intervention-records","candidate-generation-and-promotion-not-in-scope","cell-owner-context-unresolved","deposited-site-not-evaluated-or-unavailable-in-current-tier-scope","measured-compound-coverage-not-collected-for-this-target-tier"],"claim_ceiling":"no candidate, promotion, approval, site-localization, efficacy, selectivity, or patient-specific conclusion is recorded by this matrix","state":"evidence-routed-not-an-execution-record"},"proposed_molecular_jobs":[{"basis":"no observed deposited site and no normalized assigned intervention action or supported payload/imaging modality","basis_ids":["T-ENSG00000164078"],"claim_ceiling":"discovery proposal only; it does not assert that a site exists, is accessible, binds a modality, or has therapeutic activity","job":"map-an-extracellular-binder-site-then-test-occupancy","job_id":"P-JOB-DISCOVERY-T-ENSG00000164078","rule_id":"TADM-PJ-30-no-observed-site-or-action-discovery","state":"proposed-discovery-job-unresolved-activity"}],"ranking":{"evidence_rank":166,"prioritization_status":"provisional-public-cohort","state":"derived-canonical-target-prioritization","structure_resource_rank":50,"structure_tier":"structure-c"},"supported_molecular_jobs":[{"action":"unresolved","intervention_count":0,"representative_intervention_ids":[],"state":"not-measured"}],"target_id":"T-ENSG00000164078","target_identity":{"gene_symbol":"MST1R","preferred_name":"MST1R","state":"observed-canonical-target-record","uniprot_accessions":["Q04912"]}}],"schema_version":"codex-surface-target-action-modality-matrix/v0.1","source_inputs":{"actionable_sites":{"bytes":272569,"name":"actionable-sites.json","record_count":14,"schema_version":"codex-surface-actionable-site-library/v0.1","sha256":"07f5d2921fdf8345e0540003b0cb9ad50d8d42c349c95b2ae1dc26b2763d2897"},"interventions":{"bytes":1935155,"name":"interventions.json","record_count":766,"schema_version":"codex-surface-intervention-collection/v0.1","sha256":"e7935e91eee2054a968d34ed0c38104ae37343e790aa9ae0cc08c30f20586ed7"},"known_compound_interactions":{"bytes":240108,"name":"known-compound-interactions.json","record_count":57,"schema_version":"codex-surface-known-compound-interaction-collection/v0.1","sha256":"26aaa2e132443759fd200931f372de154e56b370d6ecd291299684383a3ce627"},"targets":{"bytes":2563163,"name":"targets.json","record_count":185,"schema_version":"codex-surface-target-collection/v0.1","sha256":"c6e20ca44b161b182f2c298dde20afcfb384e382a71d0926f21461aec3fd29a4"}}}